Data from multiple sources - Curated by Toby Galbraith - Last updated 04 January 2017

Latest news articles

Added 23 hours ago Drug news

Data review of Phase III study of Macrilen (macimorelin) for the evaluation of growth hormone deficiency in adults. -Aeterna Zentaris Inc.

Aeterna Zentaris Inc. announced that, following a comprehensive review of data obtained from the confirmatory Phase III clinical trial of...

Added 3 days ago Drug news

Phase III trial of Inflectra (infliximab CT-P13) meets endpoint in Crohn’s disease- Pfizer and Celltrion Healthcare

Data announced by Pfizer and Celltrion Healthcare showed that for patients with moderate-to-severe Crohn’s disease (CD), treatment with Inflectra (infliximab...

Added 3 days ago Drug news

Tivantinib fails to meet endpoint in METIV-HCC Phase III trial for hepatocellular carcinoma.- ArQule Inc. + Daiichi Sankyo

ArQule, Inc.and Daiichi Sankyo announced that the METIV-HCC phase III study of tivantinib in hepatocellular carcinoma (HCC) did not meet...

View all news articles

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

Visit Acute and Advanced Heart Failure

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

Visit Fluid Management

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more

Visit Type 2 Diabetes

 

Guidelines

American Association Of Clinical Endocrinologists And American College Of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care Of Patients With Obesity

Development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and the American College of Endocrinology...

Added 2 months ago

Evidence-based indications for the use of PET-CT in the United Kingdom 2016

Since its introduction into clinical practice in the UK 26 years ago, positorn emission tomography (PET) followed by positron emission tomography-computed tomography...

Added 2 months ago

Non-Hodgkin’s lymphoma: diagnosis and management: NICE Guidelines

This guideline covers diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over.

Added 4 months ago

View all guidelines

Journal articles

Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.

We evaluated the prognostic impact of cell-of-origin classification as well as intratumoral regulatory T cells (Tregs), macrophages, and microvessel density (MVD) on 115 patients (74 in the...

Added 21 hours ago

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Despite the generally favorable clinical course in follicular lymphoma (FL), a minority of patients have a poor prognosis-with death within 3 years of diagnosis-most often due to transformation to...

Added 21 hours ago

Double hit diffuse large B-cell lymphomas: diagnostic and therapeutic challenges.

Although diffuse large B-cell lymphoma (DLBCL) is curable with standard chemoimmunotherapy, over 30% of patients with advanced stage disease experience refractory disease or progression...

Added 21 hours ago

View all journal articles

Blog Posts

Fiona Holland

What to say and do when someone has cancer

Posted 20 days ago

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

Liam Farrell

Bad smells are good

Posted 4 months ago

Delicacy is not a virtue in this job.

Joyce Lee

Healthcare Provider: Think Like a Designer!

Posted 1 year ago

Joyce Lee puts forward the case for healthcare providers using goal-directed design. Should we treat patients in order to facilitate their personal treatment goals rather than aiming to simply reduce their symptoms? Do statistical and scientific methodologies neglect the psychosocial emotional management of patients?